Protagenic Therapeutics Reported Earnings

Protagenic Therapeutics (PTIX) reported a loss of $1.73 per share on revenue of $0.00 million for the . .

Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based in New York, United States.